1. Home
  2. KXIN vs HUGE Comparison

KXIN vs HUGE Comparison

Compare KXIN & HUGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KXIN
  • HUGE
  • Stock Information
  • Founded
  • KXIN 2015
  • HUGE 1998
  • Country
  • KXIN China
  • HUGE Canada
  • Employees
  • KXIN N/A
  • HUGE N/A
  • Industry
  • KXIN Retail-Auto Dealers and Gas Stations
  • HUGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • KXIN Consumer Discretionary
  • HUGE Health Care
  • Exchange
  • KXIN Nasdaq
  • HUGE Nasdaq
  • Market Cap
  • KXIN 7.5M
  • HUGE 7.8M
  • IPO Year
  • KXIN N/A
  • HUGE N/A
  • Fundamental
  • Price
  • KXIN $0.12
  • HUGE $0.15
  • Analyst Decision
  • KXIN
  • HUGE
  • Analyst Count
  • KXIN 0
  • HUGE 0
  • Target Price
  • KXIN N/A
  • HUGE N/A
  • AVG Volume (30 Days)
  • KXIN 1.8M
  • HUGE 2.4M
  • Earning Date
  • KXIN 11-26-2019
  • HUGE 07-22-2024
  • Dividend Yield
  • KXIN N/A
  • HUGE N/A
  • EPS Growth
  • KXIN N/A
  • HUGE N/A
  • EPS
  • KXIN N/A
  • HUGE N/A
  • Revenue
  • KXIN $31,535,000.00
  • HUGE N/A
  • Revenue This Year
  • KXIN N/A
  • HUGE N/A
  • Revenue Next Year
  • KXIN N/A
  • HUGE N/A
  • P/E Ratio
  • KXIN N/A
  • HUGE N/A
  • Revenue Growth
  • KXIN N/A
  • HUGE N/A
  • 52 Week Low
  • KXIN $0.11
  • HUGE $0.13
  • 52 Week High
  • KXIN $5.52
  • HUGE $1.68
  • Technical
  • Relative Strength Index (RSI)
  • KXIN 40.59
  • HUGE 31.84
  • Support Level
  • KXIN $0.13
  • HUGE $0.14
  • Resistance Level
  • KXIN $0.16
  • HUGE $0.15
  • Average True Range (ATR)
  • KXIN 0.01
  • HUGE 0.02
  • MACD
  • KXIN -0.00
  • HUGE 0.01
  • Stochastic Oscillator
  • KXIN 11.03
  • HUGE 34.36

About KXIN Kaixin Auto Holdings

Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.

About HUGE FSD Pharma Inc. Class B Subordinate Voting Shares

FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

Share on Social Networks: